Cantitate/Preț
Produs
Total produse
Vezi coșul
Biotechnology in the Time of Covid-19 de Jeremy M Levin

Biotechnology in the Time of Covid-19

Editat de Jeremy M Levin
en Limba Engleză Paperback – 31 mai 2020
A global, timely calling card for the biotechnology industry, and their efforts going forward during the COVID-19 pandemic. A collection of diverse viewpoints from over 40 thought leaders in the biotech industry.
Citește tot Restrânge

Preț: 11109 lei

Nou

Puncte Express: 167
Preț estimativ în valută:
2126€ • 2210$ • 1761£

Carte disponibilă

Livrare economică 15-29 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780795352973
ISBN-10: 0795352972
Pagini: 285
Dimensiuni: 140 x 216 x 17 mm
Greutate: 0.38 kg
Editura: Open Road Integrated Media Inc.

Notă biografică

Dr. Jeremy M. Levin is Chairman and CEO of Ovid Therapeutics Inc (NASDAQ:OVID), a company whose mission is to bring treatment to patients with rare neurological conditions. Dr. Levin is concurrently the chairman of the Biotechnology Innovation Organization (BIO). Prior to founding Ovid, Dr. Levin was president and CEO of Teva Pharmaceutical Industries Ltd., (TLV: TEVA) Before Teva, Dr. Levin was member of the executive committee Bristol-Myers Squibb Company (NYSE: BMY). In that capacity he was the architect of and implemented the String of Pearls Strategy, which transformed Bristol. Dr. Levin joined BMY from Novartis (SWX: NOVN) where he was global head of strategic alliances. He has served on the board of directors of various public and private biopharmaceutical companies and is currently on the board of directors of Lundbeck (OMX: LUN). Dr. Levin was voted as one of the twenty-five most influential biotechnology leaders by Fierce Biotech and one of the top three biotechnology CEOs in 2020 by The Healthcare Technology Report. He is the recipient of the Albert Einstein Award for Leadership in Life Sciences and the B¿nai B¿rith Award for Distinguished Achievement. He has practiced medicine at university hospitals in England, South Africa, and Switzerland. Dr. Levin earned his bachelor¿s degree in zoology and a master¿s degree and doctorate in chromatin structure, at the University of Oxford, and thereafter his medical and surgical degrees from the University of Cambridge where he won the Kermode Prize for his work on Captopril